Recursion Pharmaceuticals, Inc.RXRXNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
12.20%
↑ 278% above average
Average (22q)
-6.86%
Historical baseline
Range
High:18.00%
Low:-55.88%
Volatility
-1077.8%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 12.20% |
| Q2 2025 | 18.00% |
| Q1 2025 | 5.66% |
| Q4 2024 | -55.88% |
| Q3 2024 | 15.00% |
| Q2 2024 | -2.56% |
| Q1 2024 | 2.50% |
| Q4 2023 | 6.98% |
| Q3 2023 | -13.16% |
| Q2 2023 | -18.75% |
| Q1 2023 | -3.23% |
| Q4 2022 | 8.82% |
| Q3 2022 | 10.53% |
| Q2 2022 | -15.15% |
| Q1 2022 | 13.16% |
| Q4 2021 | -35.71% |
| Q3 2021 | -8.65% |
| Q2 2021 | -41.21% |
| Q1 2021 | -21.67% |
| Q4 2020 | -5.93% |
| Q3 2020 | -25.87% |
| Q2 2020 | -2.74% |
| Q1 2020 | 0.00% |